Recent studies have shown that DMF can activate Nrf2 signaling to alleviate complete Fischer-adjuvant induced arthritis in rats [17], which reveal that Nrf2 pathway targets have become an important target for pharmaceutical researchers to develop anti-RA drugs. Here, NFE2L2 is linked to arthritic joint disease.